全文获取类型
收费全文 | 6373篇 |
免费 | 287篇 |
国内免费 | 88篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 32篇 |
妇产科学 | 16篇 |
基础医学 | 514篇 |
口腔科学 | 20篇 |
临床医学 | 460篇 |
内科学 | 892篇 |
皮肤病学 | 19篇 |
神经病学 | 836篇 |
特种医学 | 124篇 |
外科学 | 100篇 |
综合类 | 458篇 |
预防医学 | 378篇 |
眼科学 | 33篇 |
药学 | 2653篇 |
1篇 | |
中国医学 | 107篇 |
肿瘤学 | 91篇 |
出版年
2023年 | 33篇 |
2022年 | 63篇 |
2021年 | 113篇 |
2020年 | 96篇 |
2019年 | 115篇 |
2018年 | 121篇 |
2017年 | 166篇 |
2016年 | 152篇 |
2015年 | 146篇 |
2014年 | 319篇 |
2013年 | 798篇 |
2012年 | 285篇 |
2011年 | 353篇 |
2010年 | 309篇 |
2009年 | 309篇 |
2008年 | 371篇 |
2007年 | 320篇 |
2006年 | 303篇 |
2005年 | 242篇 |
2004年 | 189篇 |
2003年 | 228篇 |
2002年 | 168篇 |
2001年 | 137篇 |
2000年 | 130篇 |
1999年 | 112篇 |
1998年 | 87篇 |
1997年 | 77篇 |
1996年 | 84篇 |
1995年 | 75篇 |
1994年 | 69篇 |
1993年 | 64篇 |
1992年 | 45篇 |
1991年 | 29篇 |
1990年 | 35篇 |
1989年 | 34篇 |
1988年 | 31篇 |
1987年 | 63篇 |
1986年 | 36篇 |
1985年 | 78篇 |
1984年 | 54篇 |
1983年 | 30篇 |
1982年 | 38篇 |
1981年 | 31篇 |
1980年 | 46篇 |
1979年 | 37篇 |
1978年 | 30篇 |
1977年 | 27篇 |
1976年 | 26篇 |
1975年 | 12篇 |
1974年 | 13篇 |
排序方式: 共有6748条查询结果,搜索用时 0 毫秒
1.
2.
3.
小鼠吗啡依赖纳洛酮催促戒断跳跃反应模型的建立 总被引:1,自引:0,他引:1
目的建立稳定的小鼠吗啡依赖纳洛酮催促戒断跳跃反应模型。方法小鼠连续皮下注射吗啡,以纳洛酮催促戒断跳跃反应为指标,调整吗啡给予天数(5,6,7,10d)、吗啡累积剂量(360,560,640,945,1100,1105,1200mg/kg)、每日给予吗啡的频数[一天二次(bid),一天三次(tid)]、纳洛酮催促紧前给予吗啡与否、以及纳洛酮剂量(10,20mg/kg),建立四个造模方案包括八个子方案。结果方案A、B2、C2吗啡组小鼠跳跃反应率未达100%;方案B1、C1、D2、D3、D4吗啡组小鼠跳跃次数变异系数较大。方案D1采用小鼠连续皮下注射倍增剂量的吗啡,tid×6d,每日每次剂量分别为5,10,20,40,80,160mg/kg;第7天皮下注射吗啡160mg/kg,3h后腹腔注射纳洛酮10mg/kg,吗啡组小鼠可产生显著的跳跃反应,与对照组比较差异有显著性(P<0.01),且变异系数小(CV为0.22),该方案吗啡依赖小鼠跳跃反应次数适度,离散度小。结论选用方案D1可建立稳定的小鼠戒断跳跃反应模型。 相似文献
4.
C. S. Peretti J. M. Danion F. Kauffmann-Muller D. Grangé A. Patat P. Rosenzweig 《Psychopharmacology》1997,129(4):329-338
Buprenorphine is a mu opioid partial agonist currently used as an analgesic, and being developed for the treatment of opioid
dependence. The purpose of this study was to determine the abuse liability of parenteral buprenorphine in volunteers maintained
on daily sublingual (SL) buprenorphine (8 mg). In a residential laboratory, eight volunteers underwent pharmacologic challenges
two times per week. Medication challenges were 16 h after the daily dose of buprenorphine, and consisted of double-blind IM
injections of buprenorphine (4, 8, 16 mg), the prototypic mu opioid agonist hydromorphone (9 and 18 mg), or saline. Assessments
consisted of physiologic monitoring, subjects’ self-reports, and a trained observer’s ratings of drug effects, and were collected
for 0.5 h before and 2.0 h following injection. Supplemental doses of IM buprenorphine produced opioid agonist-like effects,
indicating some abuse potential of parenteral buprenorphine in buprenorphine-maintained patients. There was incomplete cross-tolerance
to the effects of hydromorphone, suggesting that higher maintenance doses of buprenorphine may be needed to maximize clinical
efficacy. However, there was a lack of graded dose-effects for hydromorphone, suggesting that buprenorphine’s combination
of partial agonist effects and high affinity for opioid receptors may limit the magnitude of effects of supplemental full
agonists. Finally, participants tolerated cumulative doses of maintenance buprenorphine plus challenge buprenorphine without
adverse effects, suggesting higher doses of buprenorphine can be safely administered to opioid dependent patients.
Received: 22 February 1996/Final version: 23 August 1996 相似文献
5.
The development of a unifying framework for conceptualizing the commonalities in various forms of substance abuse must encompass the data base focused upon the stimulus functions of drugs. In the first instance, for example, the research on drug self-administration has provided convincing evidence of a remarkable concordance between laboratory animals and human substance abusers in the reinforcing stimulus functions of a range of chemical agents. The recognition of these cross-species and cross-drug generalities has radically changed conceptualizations of substance abuse from a reactive to a more active process and has encouraged the kind of functional analysis of drug-seeking and drug-taking that has proven productive and useful in the study of other behavioral interactions. In this regard as well, recent refinements in the analysis of the discriminative stimulus functions of drugs have provided a more comprehensive basis for characterizing a chemical agent's spectrum of action and evaluating its abuse liability. While the correlation between the discriminative stimulus functions and the reinforcing stimulus functions is remarkably high for some drug classes, there are notable exceptions. Finally, the assessment of abuse liability requires an analysis of the eliciting stimulus functions of drugs as reflected by the physiological and behavioral changes, both acute and chronic, that follow drug administration. The methods used to evaluate both physiological dependence and behavioral toxicity in relationship to sensory and motor effects for a range of abused drugs have depended heavily upon an assessment of the eliciting stimulus functions of such compounds. 相似文献
6.
目的:探讨护理程序对戒毒病人的护理模式,以促进病人积极参与戒毒,减轻戒断症状及改善吸毒导致生理、心理、社会的危害。方法:对应用护理程序工作方法的护理效果进行SPSS11.5统计分析。结果:开展后住院病人意外事件及暴力行为的发生率比开展前显著性降低,实施心理卫生教育后病人对毒品危害性及相关知识认识水平显著提高。结论:通过应用护理程序的工作方法能帮助病人进步且朝向预定目标,为病人走上康复之道打下基础。 相似文献
7.
The practicality of using second-order fixed-interval schedules in studies of heroin reinforcement with rats was examined. Optimum rates of responding were obtained with a dose of 0.03 mg/kg/infusion and an interval duration of 3 min. In addition, schedules consisting of a only a single interval were shown to be practical, leading to response rates comparable to those obtained with cocaine or food as reinforcer.The views expressed in this publication are those of the author and do not necessarily represent those of the Addiction Research Foundation 相似文献
8.
9.
《中国新药与临床杂志》1994,(5)
阿片成瘾者250例(男性222例,女性28例,年龄30±s5a)应用山莨菪碱0.5-2mg/(kg·d),分2-3次加入10%葡萄糖250mL或5%葡萄糖生理盐水500mL静脉滴注;东莨菪碱0.02-0.03mg/kg加入10%葡萄糖250mL静脉滴注1次,必要时对重患者追加1次,疗程5-7d。结果戒断症状均有改善(P<0.01),27例需加用羟丁酸钠。不良反应轻,可作为阿片瘾者的脱瘾药物。*P<0.01。碱确能解除阿片药物戒断症状。其对阿片戒断症状缓解时间在治疗4-5d后,强烈觅药渴求也随之逐渐消失。150例(60%)要求进食,175例(70%)仍需借助安眠药睡眠。另65例(26%)戒断症状阵发性发作,每次持续0.5-1h,症状轻重不一,轻者流泪、全身弥漫性疼痛,重者焦躁不安、心中猫抓虫咬样难受,甚至想自残,可配合艾司唑仑3-4mg/d,po或氯硝西泮6-10mg/d,po;也可用氯硝西泮1-2mg/次,im,每日2-3次;针刺胃俞、脾俞、中脘、足三里、印堂、太阳、百会、内关、合谷、命门、夹脊和肾俞穴位,根据临床症状任选其中3-5个穴位进行治疗或心理治疗能快速减轻患者戒断症状。治程中27例(10.8%)重? 相似文献
10.
A. Rocco J. Afra M. Toscano G. Sirimarco L. Di Clemente M. Altieri G. L. Lenzi V. Di Piero 《European journal of neurology》2007,14(12):1378-1382
The intensity dependence of the auditory-evoked potentials (IDAP) is inversely related to serotonergic tone. Depression is frequently observed after stroke, associated with cognitive impairment and increased mortality. Aim of this study was to investigate the serotonergic tone in acute stroke patients by IDAP. Consecutive patients with an acute stroke admitted in our stroke unit were evaluated using clinical and instrumental examinations and compared with healthy controls. The IDAP was calculated as the linear amplitude/stimulus intensity function (ASF) slope, by measuring the peak-to-peak amplitude of Nl-P2 on four blocks of different stimulus intensities. Twenty patients were enrolled; 11 had a right brain infarction; nine had depressive symptoms (DS). The ASF slope of the auditory-evoked potentials was markedly increased in stroke patients compared with controls ( P = 0.021). Stroke patients with DS had a significant steeper ASF slope than controls ( P = 0.017). There was no statistical difference in ASF slope between stroke patients without DS and controls. Post-stroke depression pathophysiology is still debated. Our study suggests that in acute stroke patients with DS, there is a direct involvement of the serotonergic system, regardless the degree of disability and the site of the lesion. 相似文献